Skip to content
A Green Sign – Lifestyle
Author:
Caribou Biosciences, Inc.
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
March 31, 2026
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 6, 2026
←
Previous Page
1
2